FDA.reportPublic FDA data

ABSTRAL 800 MCG Sublingual Tablet

RxCUI
1053666
RxNorm name
ABSTRAL 800 MCG Sublingual Tablet
Display name
ABSTRAL 800 MCG Sublingual Tablet
Full name
ABSTRAL 800 MCG Sublingual Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4906457e-30ad-4da7-b3ac-bb9e6651a670ABSTRAL 800 MCG Sublingual Tablet [PSN] · fentanyl 0.8 MG Sublingual Tablet [Abstral] [SBD] · Abstral (as fentanyl citrate) 800 MCG Sublingual Tablet [SY] · Abstral 0.8 MG Sublingual Tablet [SY]43These highlights do not include all the information needed to use ABSTRAL safely and effectively. See full prescribing information for ABSTRAL. ABSTRAL ® (fentanyl) sublingual tablets CII Initial U.S. Approval: 196820120229
f969e2bc-6297-4e29-89d3-a3685a2c7c6bABSTRAL 800 MCG Sublingual Tablet [PSN] · fentanyl 0.8 MG Sublingual Tablet [Abstral] [SBD] · Abstral (as fentanyl citrate) 800 MCG Sublingual Tablet [SY] · Abstral 0.8 MG Sublingual Tablet [SY]42These highlights do not include all the information needed to use ABSTRAL safely and effectively. See full prescribing information for ABSTRAL. ABSTRAL ® (fentanyl) sublingual tablets CII Initial U.S. Approval: 196820141130